Vivo Technician; Part-Time : Weekends
Listed on 2026-03-01
-
Healthcare
Clinical Research, Oncology, Medical Science
About Halda Therapeutics
Halda Therapeutics, a Johnson and Johnson company, is a clinical‑stage biotechnology company focused on the development of a proprietary RIPTAC™ (Regulated Induced Proximity TArgeting Chimeras) therapeutic that works by a novel “hold and kill” mechanism for the precision treatment of cancer. The mechanism of action of RIPTAC therapeutics is uniquely designed to address cancer’s ability to evolve bypass mechanisms of resistance, a common limitation of today’s precision oncology medicines.
Our lead RIPTAC programs are in development for major solid tumor types, prostate cancer and breast cancer, with additional RIPTAC therapeutic programs in our pipeline to treat unmet medical needs in cancer. Halda was founded by Yale Professor Craig Crews and is led by a team with deep expertise in bifunctional drug discovery, platform innovation, and company building and is located in New Haven, CT.
At Halda, our team is a collective force for drug innovation to conquer cancer. Learn more about us at
AboutThe Role
We are seeking a Part‑time In Vivo Technician to provide weekend and holiday support for our In Vivo lab.
What You’ll Do- Execution of drug formulation protocols.
- Drug administration via multiple routes (IV, IP, SC, PO).
- Observes, records, and reports atypical findings to senior personnel.
- Willing to work Saturdays and holidays – typical shifts are 4 - 8 hours on Saturdays and approximately half of the holidays.
- Bachelor’s degree in biology or related field.
- At least 1 year of animal work experience, preferably in the field of In Vivo research.
- Experience with rodent handling and dosing.
- Excellent attention to detail and strong organizational skills.
- Ability to work independently and as part of a team.
- Strong communication and interpersonal skills.
- Please note the schedule for this position before applying**
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).